Search Results 771-780 of 18951 for Neutrophil

1. Adipose-Derived Mesenchymal Stem Cells (AMSCs) For Recurrent Glioblastoma - Mayo Clinic

   Absolute Neutrophil Count (ANC) ≥ 1.5 x 10^9/L. Willing to return to enrolling institution for follow-up (during the Active Monitoring Phase of the study) ...

2. A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   No cytopenias (platelets < 100,000/µl, hemoglobin < 10 g/dl, or absolute neutrophil count < 1500/µl). Exclusion Criteria: The following criteria will prevent ...

3. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

   Absolute neutrophil count >= 1,000/uL (unsupported). Platelets >= 100,000/uL (unsupported). Hemoglobin >= 8 g/dL (may be supported). Patients with a known ...

4. A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD - Mayo Clinic

   Evidence of myeloid engraftment (absolute neutrophil count ≥0.5 x 10^9/L); Lower GI GvHD manifested by diarrhea must have other causes of diarrhea ruled out ...

5. Oligomets pancreas SBRT - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3;; Platelet count ≥ 100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN (If known Gilbert's syndrome, then ≤ 3.0 x ULN); ...

6. A Study to Evaluate Pembrolizumab for Surgically Treated Adjuvant Merkel Cell Carcinoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1000/uL: ANC: ______ Date Obtained: ______. Platelets ≥ 75 x 103/uL: Platelet: ______ Date Obtained ...

7. A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Absolute neutrophil count > 1.5 × 109/L (1500/mm3);; Platelets > 100 × 109/L (100000/mm3);; Hemoglobin ≥ 10.0 g/dL (6.2 mmol/L);; Serum total bilirubin ≤ 1.5 ...

8. A Study Of Ex Vivo Expansion (ACT-X) - Mayo Clinic

   The following laboratory values obtained ≤ 28 days prior to registration. Hemoglobin ≥910.0 g/dl. Absolute neutrophil count (ANC) ≥1500/mm3. Platelet count ...

9. An Extension Study to Evaluate the Long-Term Safety and Tolerability of NEOD001 for Treatment of People with Light Chain Amyloidosis - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1.0 ×109/L; Platelet count ≥75 × 109/L; Hemoglobin ≥9 g/dL; Total bilirubin ≤2 times the upper limit of normal (× ULN) ...

10. Publications - Meng Welliver, M.D., Ph.D. - Mayo Clinic

    Pre-treatment neutrophil-lymphocyte ratio is associated with overall mortality in localized non-small cell lung cancer treated with stereotactic body ...